Contact

Empowering Care,
One Heart at a Time

Elucid is a medical technology company that develops AI to see invisible features of cardiovascular risk.

The company is dedicated to developing a clinical platform to help physicians deliver CCTA-guided personalized care by providing a more precise view of atherosclerosis, the root cause of cardiovascular disease.

Our Mission Statement

Elucid’s mission is to predict and personalize the prevention of heart attacks and strokes.

At Elucid, we focus on enabling efficient and transparent clinical insights to help usher in the next generation of CCTA-guided, personalized coronary artery disease care. We develop AI tools to see invisible features of risk and guide personalized, precise treatment based on a detailed analysis of patients’ atherosclerotic disease. Elucid’s platform transforms CT images into a dynamic, interactive map of disease, providing a more precise view of atherosclerosis – the root cause of cardiovascular disease – to help physicians personalize care based on a patient’s individual anatomy.

A smiling couple walks arm-in-arm through a vibrant outdoor market full of fresh vegetables and flowers.

Elucid Leadership

Andrew Miller Chief Technology Officer & SVP, Engineering

Andrew Miller

Chief Technology Officer & SVP, Engineering
Linkedin
Windi Hary Chief Regulatory & Quality Officer

Windi Hary

Chief Regulatory & Quality Officer
Linkedin
Amy Kruglak SVP, People & Leadership Development

Amy Kruglak

SVP, People & Leadership Development
Linkedin
Amir Ahmadi, MD Lead Scientific Advisor

Amir Ahmadi, MD

Lead Scientific Advisor
Linkedin

News, Media & Thought Leadership

Stay informed with the latest updates, insights, and conversations from Elucid.
Type
Elucid names Richard E. Kuntz and Shamiram Feinglass as board directors; text with headshots on blue background.

Elucid Names Richard E. Kuntz, MD, MSc and Shamiram Feinglass, MD, MPH Board Directors

Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient-specific therapeutic decisions, has made two additions to its Board of Directors. The company named Richard E. Kuntz, MD, MSc and Shamiram Feinglass, MD, MPH as board directors.
  • Press Releases
News graphic: Elucid applauds CMS inclusion of plaque analysis in 2026 proposed Medicare fee schedule.

Elucid Applauds CMS Inclusion of Coronary CTA with Plaque Analysis in 2026 Proposed Medicare Physician Fee Schedule

Elucid today released a statement commending U.S. Centers for Medicare & Medicaid Services (CMS) for the inclusion of a Category I CPT code for coronary plaque analysis and a national Medicare average payment amount of over $1,000, pending the final Medicare Physician Fee Schedule (PFS) ruling, which will come out in November.
  • Press Releases
News about Elucids PlaqueIQ™ being included in eviCore coverage guidelines, with text about coronary CTA plaque.

Elucid’s PlaqueIQ Image Analysis Software Included in EviCore Coverage Guidelines

Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient-specific therapeutic decisions, today announced that EviCore, a radiology benefit manager, has updated its cardiac imaging guidelines to include coverage of coronary computed tomography angiography (CTA) plaque quantification (see pages 82-84), effective October 1, 2025.
  • In the News
News graphic announcing Elucids PlaqueIQ showcase at SCCT 2025, with a plaque diagram on the right.

Elucid to Showcase PlaqueIQ at SCCT 2025

Elucid will be featured along with its PlaqueIQTM image analysis software at the 20th Annual Meeting of the Society of Cardiovascular Computed Tomography (SCCT 2025), to be held July 17-20 at Palais des Congrès de Montréal.
  • Press Releases
News graphic announcing Dr. Robert Pelberg as SVP of Medical Affairs at Elucid, with his photo and credentials.

Elucid Appoints Dr. Robert Pelberg as New Senior Vice President of Medical Affairs

Elucid has named Dr. Robert “Bob” Pelberg as its new senior vice president of medical affairs.
  • Press Releases
Curved modern building with many windows, set against a clear blue sky with a small white cloud.

Where to Find Us: Upcoming Events

Washington Hilton – Washington, DC – March 7-10, 2026

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Click here

Stay in Touch

Subscribe to our newsletter for the latest clinical, product and regulatory updates.

Opt In
Eight people in an office sit and stand together, smiling and making heart shapes with their hands.